SOURCE: MIT Holding, Inc.

MIT Holding, Inc.

March 17, 2014 08:40 ET

Coastal Carolina Medical Center, Inc. Engages MIT Holding, Inc.'s (MITD) Compounding Pharmacy and Medical Infusion Technologies Divisions

SAVANNAH, GA--(Marketwired - Mar 17, 2014) - MIT Holding, Inc. (OTCQB: MITD) announces that Coastal Carolina Medical Center has engaged the "Compounding Pharmacy and Infusion Divisions" of MIT Holding Inc., for initial in hospital treatments of patients. These services will then expand in scope and medications. The administration of infusions will become outpatient in a MIT Holding Infusion facility. The average treatment per patient is expected to bill at an average of $923 per treatment.

Walter Drakeford, MITD's CEO, stated, "This ground breaking approach, in addition to offering services in our certified infusion centers, yield significant savings to the hospital while, also offering the same level of service to the patient in a setting absent of the 'hospital stressful' environment. The efficiencies offer to the hospital and convenience for the patient will be a blueprint approach that we would expect our future acquisition targets to emulate."

Mr. Drakeford went on to say; "This contract was structured in a manner that allows for the expansion of additional services and pharmaceuticals as needed and offered to Carolina Coastal."

Management reminds investors and other interested parties of its scheduled conference call, Tuesday, March 18, 2014, at 11:30AM ET, call-in number is #267-507-0240; access code 854127. Log in begins at 11:20 am ET.

About MIT Holding, Inc.

Through its wholly owned subsidiaries, MIT distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil. MIT's domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.

For more information, contact Mr. William Nalley, Orsay Groupe, info@orsaygroupe.com, phone 305-790-2688 and/or visit http://www.mitholdingsinc.com/home-2.

Forward-Looking Statements:
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, but there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.

Contact Information